Literature DB >> 9746164

An assessment of local curability of endoscopic surgery in early gastric cancer without satisfaction of current therapeutic indications.

Y Amano1, S Ishihara, K Amano, K Hirakawa, K Adachi, R Fukuda, M Watanabe, S Fukumoto, H Fujishiro, T Imaoka.   

Abstract

BACKGROUND AND STUDY AIMS: Therapeutic endoscopy for early gastric cancer has been established with strict criteria for indications. In the present study, we evaluated the efficacy of endoscopic treatment in cases that did not fulfil the standard therapeutic criteria, consisting of well differentiating mucosal adenocarcinomas less than 2 cm in size and without an ulcer or a scar. PATIENTS AND METHODS: Sixty nine early gastric cancers in 64 patients that did not fulfil the standard criteria were treated endoscopically, and a rate of cure was retrospectively assessed during a mean follow-up of 5.2 years. Endoscopic treatment consisted of mucosal resection or thermal methods, or both.
RESULTS: Curative resection was achieved in 19/20 (95%) of cases which came into one of the following categories, all being well differentiated adenocarcinomas, less than 3.0 cm in size, without ulcer or the scar of an ulcer, with invasion limited to mucosal layer (depth m); tumors less than 2.0 cm, with an ulcer or scar, depth m; tumors less than 2.0 cm, without ulcer or scar, invading the submucosa but in which invasion was limited to the superficial portion (depth sm-1); and poorly differentiated tumors less than 1.0 cm in size, without an ulcer or scar, depth m. The rate of cure in this group was statistically similar to the cure rate of cases that fulfilled the standard criteria (98%).
CONCLUSIONS: Our retrospective results suggest that the indications for curative treatment of early gastric cancer could be expanded. Prospective studies are required.

Entities:  

Mesh:

Year:  1998        PMID: 9746164     DOI: 10.1055/s-2007-1001342

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  Endoscopic mucosal resection and endoscopic submucosal dissection as treatments for early gastrointestinal cancers in Western countries.

Authors:  Sergio Coda; Sun-Young Lee; Takuji Gotoda
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

Review 2.  Endoscopic mucosal resection for early gastric cancer.

Authors:  Cathy Bennett; Yiping Wang; Tao Pan
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 3.  [Endoscopic submucosal dissection].

Authors:  J Hochberger; P Köhler; E Kruse; J Hûppertz; M Delvaux; G Gay; E Wedi
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

4.  Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery.

Authors:  Do-Joong Park; Hyeon-Kook Lee; Hyuk-Joon Lee; Hye-Seung Lee; Woo-Ho Kim; Han-Kwang Yang; Kuhn-Uk Lee; Kuk-Jin Choe
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

5.  Laparoscopic intragastric full-thickness excision (LIFE) of posterior gastric lesions under flexible endoscopic control--a feasibility study.

Authors:  Yoshiyuki Hoya; Makoto Yamashita; Takuya Inagaki; Katsuhiko Yanaga
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

6.  Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer.

Authors:  T Hasuo; S Semba; D Li; Y Omori; D Shirasaka; N Aoyama; H Yokozaki
Journal:  Br J Cancer       Date:  2006-12-19       Impact factor: 7.640

Review 7.  Handling and Pathology Reporting of Gastrointestinal Endoscopic Mucosal Resection.

Authors:  Bita Geramizadeh; David A Owen
Journal:  Middle East J Dig Dis       Date:  2017-01

8.  Clinicopathologic Features of Submucosal Papillary Gastric Cancer Differ from Those of Other Differentiated-Type Histologies.

Authors:  Seung Yong Shin; Jie-Hyun Kim; Myeong-Cherl Kook; Do Youn Park; Keun Won Ryu; Il Ju Choi; Sung Hoon Noh; Hyunki Kim; Yong Chan Lee
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.